Dendritic cell-based immunotherapy
Rachel Lubong Sabado(Tisch Hospital), Nina Bhardwaj(Mount Sinai Hospital)
Cited by 906
Related Papers
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
|Immunity|2016|1.2k
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
|Nature Medicine|2018|1k
Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
|Clinical Cancer Research|2012|225
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
|Cancer Cell|2022|127